The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

REGN FINANCIAL STATEMENTS

Regeneron Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

REGNRegeneron Pharmaceuticals Inc

🇺🇸 USA · US · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
05 B10 B15 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue15.5 B $Gross Profit13 B $ · 83%Operating Income3.8 B $ · 25%Pre-tax Income5.2 B $ · 33%Net Income to Owners4.3 B $ · 28%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue15.5 B $+9.3%
Gross Profit13 B $+6.5%
Operating Income3.8 B $+0.1%
EBITDA5.1 B $-6.7%
Net Income to Owners4.3 B $-2.9%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
020 B40 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets41.7 K
  • Equity31.7 K $76%
  • Current Liabilities5.5 K $13%
  • Long-term Liabilities4.5 K $11%

Key Figures

YoY change
Total Assets41.7 K $-100.0%
Total Liabilities10 K $-100.0%
Total Equity31.7 K $-100.0%
Cash & ST Investments8 K $-100.0%
Total Debt2 K $-100.0%
Net Debt-469.2 $-100.0%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
02.5 B5 B7.5 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
02 B4 B4.4 B $Operating-704.2 M $Investing-4.6 B $Financing-906.4 M $Net Change

Key Figures

YoY change
Operating Cash Flow4.4 B $-6.3%
Capital Expenditures920.9 M $+2.4%
Free Cash Flow3.5 B $-8.4%
Dividends Paid-378.5 M $-303.1%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on REGN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.